VitaLabs Season 2 — Call for Projects! We’re funding bold, high-risk longevity research. Join us to solve the toughest challenges in extending human life. Researchers keep ownership of their breakthroughs. Ready to make history? 👉Apply now: vitadao.com/vitalabs

Mark your calendars for Wed, June 11th at 2pm ET/11am PT. JellyfishDAO be hosting an X space with Jean Hebert, Ph.D. (Jean M Hébert) to discuss his work on restoring brain function via tissue engineering and more. Join us! W/ host LongevityLawson. x.com/i/spaces/1yNGa…

the Loyal team will be at BIO next week - reach out to [email protected] if you're keen to meet us. we're especially interested in in-licensing NCEs w potential for aging/longevity dev - for multiple species ;)

All Americans deserve to be healthy, happy, and prosperous. I’m excited to join Secretary Kennedy as Deputy Secretary to achieve this vision. #MAHA Please follow my official account Deputy Secretary of HHS Jim O'Neill

Can less weight loss be better weight loss? This morning at ADA, Eli Lilly released data on the Believe Phase 2b study of Bimagrumab in combination with a GLP-1 (Semaglutide) The goal: lose only fat Approach: anorectic + anabolic

📣 Evidence drives science, but stories drive change. We’ve got the data. The clinical trials. The potential to radically extend healthspan and prevent disease. Now we need you to speak up and get involved! If you believe in the promise of longevity science and want to help

Who thinks Intrinsic Capacity should be tested in response to gero-therapeutics in large scale aging human studies?

Big news: we’re kicking off the search for ARIA’s next CEO. This is a once-in-a-lifetime opportunity to lead one of the most ambitious orgs in science and tech. 1/8

The internet, mRNA vaccines, and self-driving cars all came from ARPA-style programs led by technical visionaries. Yet there’s no systematic pathway for technical visionaries to get the skills and support needed to develop such programs. Big news 👇

Join us in Crete to discuss Stem Cells. The early bird deadline has been extended to July 15th. This date will be the final deadline for abstracts being considered for short talks. aegeanconferences.org/src/App/speake…

During my talk I specifically called out these gene therapy clinics and they way they are operating. I suggested one improvement would be an independent body that collects and aggregates the data on both efficacy and adverse events. Afterward folks from the conference shared some

Healthspan Effects of an Anti-Aging Vaccine on Mice The vaccine partly restored age-related NAD+ decline. Anna Drangowska-Way Lifespan News lifespan.io/news/healthspa…

Important update on Alzheimer's -Need to start prevention much earlier than waiting for symptoms. nih.gov/news-events/ne… National Lipid Association European Atherosclerosis Society ASPC European Society of Cardiology International Atherosclerosis Society (IAS)

People should be free to choose what they do with their bodies—but freedom is only meaningful if the information is accurate, balanced, complete. Overselling benefit and downplaying risk with something as complex & irreversible as gene therapy isn't innovation — it's exploitation

PROSPR will identify therapeutic solutions to prevent associated functional declines. The mechanisms that reverse functional declines in the elderly (rejuvenation) are likely different. Who is doing exciting work in the rejuvenation space and what are some exciting opportunities

One of the great pleasures of working as a PM at ARPA-H is that I get the chance to speak with all potential performers to clarify the decisions made to encourage or discourage proposals, and to take questions. It provides a layer of transparency and accountability to the

How can we translate cutting-edge geroscience into medicines that will benefit humanity? This week's special episode features a live panel from the 25th Bay Area Aging Meeting, where six leading voices across academia, industry, and publishing tackled the critical challenge of

I couldn’t agree more with Matt Kaeberlein here. These limitations are why we built PROSPR🖖🏻

LETS GO! A new high impact program from ARPA-H. FRONT will restore lost function to the brain. Congrats to Jean M Hébert and team.

Senolytic Update "Overall, I would not put money down on senolytic therapy emerging as a viable anti-aging strategy anytime in the near future." science.org/content/blog-p…